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ABSTRACT
Objectives: Quadratus Lumborum Block in contrast to Transversus Abdominis Plane Block contains a unique component 
which not only stops somatic pain but also inhibits visceral pain by spreading the local anesthetic to the paravertebral 
space. This study was designed to determine whether performing the Quadratus Lumborum Block type I in patients un-
dergoing cesarean section would be associated with both decreased morphine consumption and decreased pain levels 
in the postoperative 48-hour period.
Material and methods: Sixty patients undergoing caesarean section under spinal anesthesia were randomly and equally 
assigned to one or other of two groups: QLB I (who received Bilateral Quadratus Lumborum Block type I with the use of 
24 mL 0.375% ropivacaine per side) or a Control group. In both groups, on-demand morphine analgesia was administered 
postoperatively within the first 48 hours. The following were measured: the morphine consumption; the time elapsed from the 
C-section until the first dose of morphine; and the levels of pain intensity among patients in rest (numeral pain rating scale).
Results: There were no statistically significant demographic data differences between the QLB I and Control groups. The 
following significant differences were observed in the 48-hour postoperative period: morphine consumption was higher 
in the Control group (p = 0.000); the time elapsed from the C-section until the first dose of morphine was longer in QLB 
I group (p < 0.05); and the median of the pain numeric rating scale was higher in the Control group (p < 0.05).
Conclusions: Quadratus Lumborum Block type I significantly reduces morphine consumption and pain levels up to 
48 hours postoperatively.
Key words: quadratus lumborum block type I, ropivacaine, cesarean section, multimodal analgesia
Ginekologia Polska 2018; 89, 2: 89–96
INTRODUCTION
A cesarean section is the most commonly performed 
surgery in gynecology and obstetrics in the world, which 
is a steadily increasing trend [1]. The intensity of postop-
erative acute pain among patients after a C-section results 
from the development of somatic and visceral pain which 
occurs due to cutting the structures of the abdominal wall 
and the uterus [2, 3]. Unsuccessfully conducted analgesia 
after a C-section results in considerable suffering in newly 
delivered mothers, who consequently may be less willing 
to feed and care for the new-born [4, 5]. Additionally, unsuc-
cessfully conducted analgesia may impair early ambulation 
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and it poses one of the risk factors for chronic pain in the 
abdomen, and pelvis [6]. To achieve effective analgesia, 
a multimodal strategy should be used with simultaneously 
administered painkillers from all three levels of the analge-
sic ladder in conjunction with specialized peripheral nerve 
block techniques and with either continuous epidural or 
spinal anesthesia [7, 8]. For several years now, one can notice 
a real renaissance in regional anesthesia of the anterolateral 
abdominal wall after a C-section, mainly due to the intro-
duction of ultrasonography (USG) during nerve block pro-
cedures [9]. This has resulted in numerous studies proving 
its effectiveness, mainly through the reduction of somatic 
components of postoperative pain [10]. Currently, the most 
popular regional block after a C-section is Transversus Ab-
dominis Plain Block (TAPB) [10–12]. Dozens of clinical trials 
and their meta-analyses show that TAPB, as a component 
of multimodal pain therapy, provides effective analgesia 
after a C-section within the field of somatic pain which 
in fact is only coming from the abdominal wall [10–12]. 
Conducting research on a new access to TAPB using ultra-
sound led to the Quadratus Lumborum Block (QLB) [13, 14]. 
A unique component of the QLB is not only that it stops 
somatic pain but also that it inhibits visceral pain due to the 
spread of the local anesthetic to the paravertebral space. 
The analgesic’s effectiveness and superiority over TAPB after 
a C-section from a posterior approach (QLB II) were shown by 
Blanco [14–16]. We hypothesized that QLB type I as part of 
a multimodal analgesic regimen would result in decreased 
opioid consumption and improved analgesia in the first 
48 hours after a C-section. The aim of this study was to test 
this hypothesis and to observe any side effects in patients 
undergoing elective C-section via Pfannenstiel abdominal 
wall incision under spinal anesthesia.
MATERIAL AND METHODS
After approval from the Bioethics Committee at the 
University of Warmia and Mazury, on 25 June 2014, ref-
erence number 21/2014, written informed consent was 
obtained from 60 ASA II patients scheduled for elective 
C-sections via Pfanenstiel incision under spinal anesthe-
sia. The exclusion criteria were as follows: any history of 
relevant drug allergy/sensitivity; pregnancy-induced hy-
pertension; gestation diabetes mellitus; coagulopathy; 
anatomical abnormalities of abdomen; and abuse of tran-
quilizers, paracetamol or opioids. Patients were randomised 
by using a website (http://www.randomization.com) and 
a computer-generated table of unallocated numbers; thus, 
determining who would receive a bilateral Quadratus Lubo-
rum Block type I (QLB I group, n = 30) or be excluded from 
this block (Control group, n = 30). In the operating room, 
an intravenous cannula (a 16-gauge) was inserted in the 
hand or arm to all patients who were then monitored by 
electrocardiogram and non-invasive arterial blood pres-
sure; and their peripheral pulse oximetry and diuresis were 
checked. Patients received spinal anesthesia in the sitting 
position at the L3–4 interspace with 12.5 mg 0.5% hyper-
baric bupivacaine (Marcaine Heavy Spinal, Astra Zeneca) and 
20 µg fentanyl (Polfa Warszawa) injection. Afterwards, partu-
rients were placed in the supine position with 150 left uterine 
displacement. The crystalloids and ephedrine iv were admin-
istered as needed to treat hypotension. The oxygen supply 
was delivered through a facemask at 6 L/min. A C-section 
was permitted to proceed after Th6 sensory block assessed 
by loss of cold and touch. Patients received an iv infusion 
of 10 IU oxytocin (Gedeon Richter Plc.) after delivery and 
a prophylactic metoclopramide 10 mg (Metoclopramidum 
0,5%, Polpharma) iv was administered. At the end of the 
surgery patients received paracetamol 1g iv (Perfalgan, 
Bristol-Myers Squibb). 
Interventions
After wound closure, in the patients allocated to the QLB 
I group, the Quadratus Lumborum Block I was performed 
using the following aseptic techniques. The patient was 
placed in the lateral position, the skin was sanitized with 
antiseptic solution. At the beginning a convex 6 MHz ultra-
sound probe (BK Flex Focus 400) with a protective sheath 
was placed above the lateral edge of the rectus muscle and 
USG imaging depth and gain was set. Next, the probe was 
inserted in the intracranial direction towards the iliac crest 
until three bellies of abdominal muscles were visualized. 
Following the internal oblique and transversus abdominis 
muscles, the quadratus lumborum was identified with its 
adherent to the lateral edge of the transverse process of the 
L4 vertebral body and the intermediate layer of the thora-
columbar fascia. Also, the erector spinae muscle and psoas 
major muscle were visualized, together giving a recogni-
sable pattern of a three-leaf shamrock well described in the 
Shamrock Block technique. A 20-guage 10 mm Stimuplex 
Ultra 360 needle (BBraun, Melsungen AG, Germany) was at-
tached with 100 mm flexible tubing to a syringe filled with 
0.9% saline and was inserted in-plane to the probe from 
medial to lateral and moved until the point of injection was 
placed at the anterolateral border of the QLM and above the 
junction with the transversalis fascia (Fig. 1). Then, 5 mL of 
0.9% saline was injected to visualize the solution spread and 
to confirm the needle placement. Patients in the QLB I group 
received 24 mL of 0.375% ropivacaine (Ropimol, Molteni) per 
side (in total 180mg) (Fig. 2). This solution was injected after 
aspiration in 4 mL increments. The identical technique was 
repeated on the opposite side. After the procedure, patients 
were transferred to the post-anesthesia care unit (PACU) 
where their heart rate, non-invasive arterial blood pressure, 
respiratory rate, peripheral pulse oximetry and dieresis were 
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measured. Nurses providing postoperative care were given 
no information about which patient belonged to which 
study group. Over the next 48 hours, all patients received 
1 g of paracetamol iv at constant intervals of time (every 
6 hours) and 5 mg of morphine subcutaneously depending 
on their intensity of pain (NRS > 3), or, on demand with the 
proviso of a 4-hour administration frequency. Next, the the 
level of pain intensity was evaluated, only in rest among the 
newly delivered mothers (using NRS scale 0–10 in which 
0 = no pain and 10 = worst pain imaginable) and consecu-
tively after 2, 4, 8, 12, 16, 20, 24, 30, 36, 42 and 48 hours. At 
every postoperative time-point the following parameters 
were measured: sedation (Ramsey scale); nausea, vomiting 
and itching (0 = none, 1 = mild, 2 = moderate, 3 = severe); 
the possibility of the free movement of limbs or any other 
possible side effects. The primary outcome measure in this 
clinical study was 48 h morphine consumption. Secondary 
outcome measures included NRS scores, time elapsed to 
the first request for morphine and any side effects associa-
ted with morphine consumption and the block technique.
Statistical analysis
Reviewing the literature in 2014, we did not identify 
any previous studies comparing QLB type I or II with 48 h 
morphine consumption or NRS pain scores after C-section. 
The minimum patient number in each study group was 
calculated based on the data from the pilot study of 
10 patients, in whom the 24 h morphine requirement was 
25 mg. We considered that a clinically important difference 
in 24 h morphine consumption would be a 25% absolute 
reduction in the QLB I group compared with the control 
group. We elected to recruit 30 patients per group into the 
study based on a calculation of 0.05 and a power of 0.8, to 
minimize any effect of data loss,. The results were analysed 
by using SPSS Statistics (ver. 19, SPSS Inc, USA) and taking 
as the level of significance p = 0.05. Data was assessed for 
normality based on the results of the Shapiro-Wilk test. 
Statistical descriptions of the analysed variables included 
the numerical amount, the minimum and maximum value, 
median, mean and standard deviation. In the case where 
the variables exhibited a normal distribution, a parametric 
t-Student test was used in two independent groups. In 
turn, when distributed values were different from normal, 
a non-parametric Mann-Whitney U test was applied. The 
Chi-square test was used to compare differences between 
the variables obtained. 
RESULTS
Sixty patients were enrolled in the study. Two patients 
from the QLB I group were excluded because of postopera-
tive analgesic protocol violations, so results for fifty-eight 
patients were analyzed in total (Fig. 3). The groups did not 
differ in terms of demographic data (Tab. 1). Our study 
compares the two groups’ morphine consumption, by 
comparing morphine use across the 48-hour period; and 
by comparing consumption between day 0 and day 1; to 
identify statistically significant differences (Tab. 2). In the 
group of patients who underwent the QLB I block, there 
was a statistically lower use of morphine at 4-hour inter-
vals, in contrast with the control group (Tab. 3). Another 
statistically significant difference between the groups was 
the time elapsed from the C-section until the first dose of 
morphine, which amounted to 222 minutes on average 
in the Control group and 618 minutes in the QLB I group 
(Tab. 4). Statistically significant differences were also de- 
monstrated between the two study groups when assessing 
Figure 2. Ultrasound-guided Quadratus Lumborum Block Type I i II 
(QLB I i QLB II)
Figure 1. Diagram of abdomen cross section above the iliac crest (L4) 
TQLB — Transmuscular Quadratus Lumborum Block; QLB — Quadratus Lumborum 
Block type I & II, TAPB  — Transversus Abdominis Plane Block; A — spinal cord; 
B — ventral ramus of spinal nerve; C — body of lumbar vertebral (L4); ES — erector 
spinae muscle; PM — psoas major muscle; QLM — quadratus lumborum muscle; 
EOM — external oblique muscle; IOM — internal oblique muscle; TAM — transversus 
abdominis muscle; RM – rectus abdominis muscle
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IOM
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B
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Figure 3. Consort statement
Enrollment
Allocation
Follow-up
Analysis
Assessed for eligibility (n = 60)
Excluded (n = 0)
• Not meeting inclusion criteria (n = 0)
• Declined to participate (n = 0)
• Other reasons (n = 0)
Randomized (n = 60)
Allocated to intervention (n = 30)
• Received allocated intervention (n = 30)
• Did not receive allocated intervention (n = 0)
Allocated to intervention (n = 30)
• Received allocated intervention (n = 30)
• Did not receive allocated intervention (n = 0)
Analysed (n = 28)
• Excluded from analysis (n = 2)
Analysed (n = 30)
• Excluded from analysis (n = 0)
Lost to follow-up (n = 0) Discontinued 
intervention (n = 0)
Lost to follow-up (n = 0) Discontinued 
intervention (n = 0)
CONSORT 2010 Flow Diagram
Table 1. Demographic data
Control group (N = 30) QLB I group (N = 28)
P value
Median Mean SD 95% Cl Median Mean SD 95% Cl
Height [cm] 167.50 167.80 5.64 165.69–169.91 165.00 166.71 4.93 164.80–168.63 0.39
Weight [kg] 85.00 82.57 14.26 77.24–87.89 80.00 79.96 9.79 76.17–83.76 0.44
Age [years] 29.15 29.29 4.55 27.59–30.99 27.800 28.746 3.25 27.49–30.01 0.82
BMI [kg/m2] 32 30.63 4.85 28.82–32.45 31 30.43 4.09 28.84–32.01 0.64
SD — standard deviation; QLB — Quadratus Lumborum Block
Table 2. Cumulative use of morphine with the division on day 0 and 1, and a total of 48 hours
Control group (N = 30) QLB I group (N = 28)
Mean range Range Median Mean range Range Median P value
Morphine use (mg) day 0 41.1 1233 20 17.07 478 10 0.0000
Morphine use (mg) day 1 36.6 1098 10 21.89 613 5 0.0001
Morphine total dose (mg) 48hours 41.77 1253 30 16.36 458 15 0.0000
QLB — Quadratus Lumborum Block
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the levels of intensity of pain reported by patients, using 
the NRS scale at these intervals: after 2, 4, 8, 12, 16, 20, 24, 
30, 36, 42, and 48 hours from the C-section (Tab. 5). No 
difference was noticed between the groups when it came 
to sedation, nausea, vomiting and itching; or free limb 
movement or other possible side effects.
DISCUSSION
Opioids continue to play an undisputed role in the treat-
ment of acute pain after C-sections; most often applied 
systemically and/or into the subarachnoid space [17]. In-
travenous administration of opioids is recommenced, using 
the Patient Controlled Analgesia method (PCA) [4, 8]. In 
Table 3. Use of morphine at 4-hour intervals by the patients from control group and who underwent the QLB I block
Control group (N = 30) QLB I group (N = 28)
4-hour intervals No (%) who use morphine No (%) who use morphine P value
0–4 h 20 (67%) 0 (0%) p < 0.05
4–8 h 23 (77%) 2 (7%) p < 0.05
8–12 h 22 (73%) 22 (79%) P = 0.64
12–16 h 20 (67%) 10 (36%) p < 0.05
16–20 h 18 (60%) 17 (61%) p = 0.96
20–24 h 10 (33%) 11 (39%) p = 0.64
24–28 h 17 (57%) 6 (21%) p < 0.05
28–32 h 16 (53%) 7 (25%) p < 0.05
32–36 h 18 (60%) 6 (21%) p < 0.05
36–40 h 6 (20%) 3 (11%) p = 0.33
40–44 h 5 (17%) 3 (11%) p = 0.51
44–48 h 0 (0%) 2 (7%) p = 0.14
QLB — Quadratus Lumborum Block
Table 4. Time to first morphine use in minutes
Control group (N = 30) QLB I group (N = 25)
P value
Min Max Median Mean SD Min Max Median Mean SD
Time (min.) 95 425 202.5 221.67 77.96 330 990 630 618.4 128.21 p = 0.000
SD — standard deviation
Table 5. Numeral Rating Scale (NRS) pain scores on days 0 and 1 postoperatively
NRS at rest (0–10)
Control group (N. = 30) QLB I group (N. = 28)
P value
Median Variance Median Variance
0 h postoperative 0 (0–0) 0.000 0 (0–0) 0.000 NS
2 h 3 (2–4) 0.372 0 (0–2) 0.476 p = 0.000
4 h 3 (0–7) 1.131 1 (0–4) 1.053 p = 0.000
8 h 3 (2–5) 0.574 2 (0–3) 0.847 p = 0.000
12 h 3 (2–6) 0.740 2 (0–3) 0.513 p = 0.000
16 h 3 (1–6) 1.306 2 (1–4) 0.851 p = 0.001
20 h 3 (2–5) 0.516 2 (0–4) 0.804 p = 0.000
24 h 3 (1–6) 0.861 2 (0–3) 0.757 p = 0.000
30 h 3 (2–5) 0.547 1 (0–3) 0.630 p = 0.000
36 h 3 (2–5) 0.648 1 (0–4) 0.988 p = 0.000
42 h 2 (1–4) 0.616 1 (0–3) 0.670 p = 0.000
48 h 1 (0–3) 0.340 0 (0–1) 0.247 p = 0.000
IQR — interquartile range; NS — not sagnificant; QLB — Quadratus Lumborum Block
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the opinion of numerous authors, the most effective and 
longest-lasting analgesic (11–24 hours) in the postopera-
tive period among patients after a C-section, is exhibited by 
morphine used as a component of spinal anesthesia [17, 18]. 
The side effects and limits in systemic and intrathecal us-
age of opioids after a C-section are: respiratory depression, 
nausea and vomiting, itching, excessive sedation, slowing 
peristaltic intestine activity and pruritus [19]. One cannot 
ignore the possibility of using Tramadol, which, in many 
cases of post-operative pain therapy after laparotomy, is 
more positive than morphine because, for example, there 
is less risk of pruritus and of respiratory depression [20]. 
Regional anesthesia used with non-opioid analgesics aims 
to reduce the total dose of opioids taken by patients during 
both the intra- and post-operative periods, which is the main 
point of multimodal analgesia [8]. 
Various analyses showed that the Transversus Abdomi-
nis Plane Block (TAPB) is an effective tool to fight postopera-
tive pain in terms of reducing the total dose of opioids, but 
only when spinal morphine is not used [21, 22]. Carney et 
al. demonstrated, by using an MRI of the chest and abdo-
men, when comparing between four groups of volunteers, 
that the spread of LA after TAPB occurs only in the area 
of the transversus abdominis plane, determining a slow-
down of only somatic pain and providing a sensory block 
only within the scope of the innervation of Th9-Th10 or 
Th11-L1. Conversely, the block within the QLM revealed 
the spread of the contrast towards the paravertebral space 
between Th4-L1 spaces [10, 13, 23]. The aim of our study 
was to confirm what Blanco indicated in 2007, that a new 
concept of the block of the abdominal wall of the inhibitory 
effect of somatic and visceral pain, the so called paraverte-
bral block component, was beneficial [14, 15]. There were 
no published studies evaluating the effectiveness of the QLB 
I and post-cesarean section until 2014, when the protocol of 
the clinical trial presented here was developed. According 
to various studies published since 2015, the QLB and its 
variants are an effective analgesic tool compared with the 
TAPB due to the absence of the paravertebral component; 
a smaller scope of activities; and the possibility of fewer 
complications [15, 16, 24].
In the presented study the focus has been on the as-
sessment of pain in the postoperative period during the 
first 48 hours (day 0 and 1) after a C-section. Among other 
researchers, the most frequently used observation time 
was a 24-hour cycle [11]. In contrast, the evaluation of pain 
intensity for a period of 48 hours after a C-section, was 
conducted among some authors after applying TAPB,; and 
by Blanco at al. after application of QLB II [14, 18, 25]. One of 
the main methods of assessing the effectiveness of analgesic 
QLB I was to compare the use of morphine for patients in 
two study groups [11, 14]. In our study of a Control group 
and the QLB I group, the median of the total morphine dose 
administered subcutaneously in the first 24 hours was 20mg 
and 10mg respectively; and during the first 48 hours 30 mg 
and 15 mg respectively. This result compares with other 
authors’ studies which evaluated morphine consumption by 
PCA iv during the first 24 hours, where performing the QLB II 
or TAPB had results of 7.5 mg, 18 mg, 19 mg and 25 mg 
across the different studies [14, 21, 22, 26].
A comparison of our study’s two research groups’ results 
for the four-hourly intervals gave interesting results. Du- 
ring the first 8 hours after a C-section as many as 70% more 
patients took morphine in the control group comparing 
with the QLB I group. Then, also worth noting is the pe-
riod between 8 and 12 hours after the C-section, where 
conversely, the morphine consumption was higher by 6% 
in the QLB I group. This sudden change in the morphine 
demand by the QLB I group from 7% to 79%, and the con-
stancy in the control group (77% and 73% respectively for 
the two periods), clearly indicates the period when the 
effects of the analgesic block disappeared. The difference 
in the timing of the QLB I group’s morphine requirement is 
reflected in the calculated difference of the timing of the 
first dose of morphine (10 hours and 18 minutes on ave-
rage); compared with that of the Control group which was 
at 3 hours and 42 minutes on average. The next period of 
morphine usage in the Control group was statistically higher 
than the QLB I group by 30% and was observed between the 
12 and 16 hours; and again between 24 and 36 hours from 
the time of the C-section. This difference, occurring during 
the first 12 hours of the second day, may suggest that the 
QLB I patients experienced less pain after night time due 
to a reduction of the first stage of postoperative pain by 
the use of block, and thus, may indicate that the use of the 
block could help to reduce pain for a further period of the 
patient’s hospital stay [27].
The author applied the NRS scale to the subjective as-
sessment of pain intensity among patients. Among other 
researchers of analgesic efficacy of TAPB and QLB after 
a C-section, VAS was the most frequently used scale [28]. 
The comparison of pain intensity assessments between the 
two groups in our study showed that in the Control group 
the maximum pain intensity rating reached 7 points with 
a median of 3 points; while in the QLB group the maximum 
pain intensity rating did not exceed 4 points, with a me-
dian between 1 and 2 points. Much better results from the 
VAS scoring was reported by Blanco et al., where, for the QLB 
group, the maximum pain intensity score was 3 points, with 
a median of 0; and in the Control group the maximum pain 
intensity score was 5 points, with a median of 3 points [29]. 
According to the recommendations of Hartrick et al., and 
Noblet et al., the pain therapy is well run in the postopera-
tive period if the assessment of NRS or VAS does not exceed 
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3 points [29, 30]. Our literature review shows that many 
other authors of clinical trials of postoperative analgesia 
after a C-section also struggled with insufficiently effective 
pain treatment, showing results of NRS or VAS > 3 [31]. The 
more favorable results obtained by Blanco et al. for both 
the assessment of pain intensity using the VAS scale and 
the total consumption of morphine, especially in the first 
12 hours in both study groups, arose mainly from the lack of 
the use of a controlled analgesia by the patient (PCA) [14]. 
The differences between our findings and those of 
Blanco et al. may also occur due to the different place at 
which the deposit of LA is made within the QLM by Blanco 
et al., meaning more from the rear side, described as QLB 
II by Blanco and McDonnell [14]. In our study by contrast, 
the LA was deposited according to the original 2007 con-
cept, i.e., from the side of the anterolateral abdominal wall 
and next to the fascia transversalis, which is QLB I [14, 16]. 
Another important difference between our study and that 
of Blanco et al., which can affect the outcome of the ef-
ficiency of analgesic QLB, was the type, concentration and 
volume of the LA used. In our study, to avoid the possible 
toxic effects of bupivacaine, which was used in the study 
by Blanco et al. and other authors, we performed the QLB 
by using the less-toxic ropivacaine (though of a weaker 
efficiency than bupivacaine), which had also often been 
used by other researchers working on the effectiveness of 
analgesic TAPB [22, 32].
During the study, there were no adverse effects of the 
QLB applied, the most dangerous of which could be the 
patient experiencing Local Anesthetic Systemic Toxicity 
(LAST) caused by intravascular administration of the LA 
or associated with exceeding a total dose of the LA [33]. 
Thanks to the performance of ultrasound and the aspira-
tion manoeuvre, safety of the procedure was significantly 
increased [9, 34].
Among the limitations of our method, we must mention 
the failure of using the PCA method due to the lack of proper 
equipment. Another limitation was the subcutaneous sup-
ply of morphine on demand in the event of pain, with a con-
stant dose of 5 mg and a minimum time interval of 4 hours 
between doses. Perhaps a better comparison between our 
two study groups would be obtained by if the study was 
blinded, achieved by performing QLB in both groups, but 
by using 0.9% NaCl solution in the Control group.
CONCLUSIONS
Considering the results of the statistical analysis, our 
observations and answers to the survey, it can be concluded 
that the method of the Quadratus Lumborum Block type I is 
a safe and well tolerated procedure by patients undergoing 
cesarean sections. Based on both subjective and objective 
methods for assessing pain intensity, it was indicated that 
QLB I significantly reduced pain among patients. There was 
no occurrence of any danger to life or health side effects 
associated with the implementation of the QLB I block or 
due to the use of ropivacaine. 
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